Research training in respiratory biology
Research training in respiratory biology
批准号:
10696963
负责人:
Yun Fang
金额:
$88.92万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
未结题
起止时间:
1985-08-01 至 2025-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The objective of our competing renewal application for the Univ of Chicago Research Training Program in
Respiratory Biology is to prepare young scientists to pursue research careers addressing mechanisms and
treatment of human disease, with a focus on respiratory pathobiology. The cohesiveness of this interdiscipli-
nary Program stems from the highly collaborative nature of our 38 well-funded faculty in 7 departments and the
Institute for Molecular Engineering at the Univ of Chicago in multiple areas of concentration. Studies in Asthma
and Airway Physiology/Immunology continue to focus on airway inflammation, airway smooth muscle and
epithelial structure and function, B-cell and T-cell activation, asthma genetics, and clinical investigation. These
complement programs of Studies in Lung Immunology and Transplantation that focus on cellular and molecular
mechanisms underlying transplantation immunology and their translational applications to patients, and
translational Studies in Interstitial Lung Diseases that draw on one of the largest dedicated clinics in the
Midwest. A Concentration in Airway and Mucosal Microbiome adds this critically important emerging research
direction to the asthma and ILD programs. Studies in Critical Illness and Acute Lung Injury continue to address
subcellular determinants of oxygen sensing and consumption, cellular responses to hypoxia, membrane
biology, endothelial and epithelial barrier function, and bedside translations to patients with sepsis,
cardiopulmonary arrest, and sleep disturbance. Complementing these are cross-cutting Studies in Genetics
and Epigenetics and Concentration in Health Studies and Ethics. The Program Directors are Anne I. Sperling,
PhD and Julian Solway, MD, with Associate Director Steven White, MD (Mentorship and Career Development).
Christopher Olopade, MD, MPH chairs a Diversity Committee. Internal and External Advisors provide oversight
and continuity of review, and an Admissions/Steering Committee reviews trainee progress. We request funding
for 10 post-doctoral trainees. PhD, MD, and MD/PhD trainees are enrolled and trained together. Collaboration
of basic and clinical scientists on research further enhances the integrative and translational nature of our
program. All fellows perform full-time research for at least 2 years, and MD fellows will devote not more than
10% time to clinical training while supported by this Program. Training consists of 5 major components:
a Research Project performed under the direct supervision of faculty co-mentors; a Core Curriculum of robust
seminar series and courses with additional, tailored formal coursework; Core Competencies that includes
scientific communication, grant writing, and mentoring; Multidisciplinary Research; and Individualized Career
Development Planning. Prior trainees from this Program have developed successful independent research
careers in large proportion. Refinements presented here should further enhance the likelihood for success of
future trainees.
期刊论文(224)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
IL-6 Inhibition in Critically Ill COVID-19 Patients Is Associated With Increased Secondary Infections.
重症患者的IL-6抑制作用与继发感染增加有关。
DOI:
10.3389/fmed.2020.583897
发表时间:
2020
期刊:
Frontiers in medicine
影响因子:
3.9
作者:
[Kimmig LM, Wu D, Gold M, Pettit NN, Pitrak D, Mueller J, Husain AN, Mutlu EA, Mutlu GM]
通讯作者:
Mutlu GM
DOI:
10.1097/ccm.0000000000004468
发表时间:
2020-09
期刊:
Critical care medicine
影响因子:
8.8
作者:
[Mayampurath A, Churpek MM, Su X, Shah S, Munroe E, Patel B, Dligach D, Afshar M]
通讯作者:
Afshar M
DOI:
10.1016/j.jaci.2015.10.017
发表时间:
2016-05
期刊:
The Journal of allergy and clinical immunology
影响因子:
--
作者:
[Denner DR, Sangwan N, Becker JB, Hogarth DK, Oldham J, Castillo J, Sperling AI, Solway J, Naureckas ET, Gilbert JA, White SR]
通讯作者:
White SR
DOI:
10.1016/j.cellsig.2010.03.016
发表时间:
2010-09
期刊:
Cellular signalling
影响因子:
4.8
作者:
[Sethakorn N, Yau DM, Dulin NO]
通讯作者:
Dulin NO
DOI:
10.7554/elife.77457
发表时间:
2022-07-13
期刊:
ELIFE
影响因子:
7.7
作者:
[Woods, Parker S., Kimmig, Lucas M., Sun, Kaitlyn A., Meliton, Angelo Y., Shamaa, Obada R., Tian, Yufeng, Cetin-Atalay, Renguel, Sharp, Willard W., Hamanaka, Robert B., Mutlu, Goekhan M.]
通讯作者:
Mutlu, Goekhan M.
共 112 条
Precision nanomedicine targeting novel endothelial mechano-sensing mechanisms
-
批准号:10630052
-
项目类别:
-
资助金额:$81.1万
-
财政年份:2022
-
负责人:Yun Fang
-
依托单位:
Precision nanomedicine targeting novel endothelial mechano-sensing mechanisms
-
批准号:10354607
-
项目类别:
-
资助金额:$80.52万
-
财政年份:2022
-
负责人:Yun Fang
-
依托单位:
Coronary artery disease locus 1p32.2 and miR92a-PPAP2B signaling in endothelial mechanobiology
-
批准号:10171493
-
项目类别:
-
资助金额:$39.9万
-
财政年份:2017
-
负责人:Yun Fang
-
依托单位:
Spatial Delivery of MicroRNA Inhibitor via Targeted Polyelectrolyte Complex Micelles to Treat Atherosclerosis.
-
批准号:10229491
-
项目类别:
-
资助金额:$39.48万
-
财政年份:2017
-
负责人:Yun Fang
-
依托单位:
Coronary artery disease locus 1p32.2 and miR92a-PPAP2B signaling in endothelial mechanobiology
-
批准号:9539874
-
项目类别:
-
资助金额:$39.9万
-
财政年份:2017
-
负责人:Yun Fang
-
依托单位:
Spatial Delivery of MicroRNA Inhibitor via Targeted Polyelectrolyte Complex Micelles to Treat Atherosclerosis.
-
批准号:10004707
-
项目类别:
-
资助金额:$39.48万
-
财政年份:2017
-
负责人:Yun Fang
-
依托单位:
miR-10a regulation of regional arterial endothelial phenotypes in atherosclerosis
-
批准号:8639625
-
项目类别:
-
资助金额:$23.7万
-
财政年份:2013
-
负责人:Yun Fang
-
依托单位:
miR-10a regulation of regional arterial endothelial phenotypes in atherosclerosis
-
批准号:8653985
-
项目类别:
-
资助金额:$24.37万
-
财政年份:2013
-
负责人:Yun Fang
-
依托单位:
miR-10a regulation of regional arterial endothelial phenotypes in atherosclerosis
-
批准号:8247722
-
项目类别:
-
资助金额:$8.6万
-
财政年份:2011
-
负责人:Yun Fang
-
依托单位:
miR-10a regulation of regional arterial endothelial phenotypes in atherosclerosis
-
批准号:8111489
-
项目类别:
-
资助金额:$8.6万
-
财政年份:2011
-
负责人:Yun Fang
-
依托单位:
海外基金